ItalyItaly

Liver Cancer Prognosis

07.06.2004

Siena/Naples - The expression of the tumour-suppressing gene Rb2/p130 and the protein Vascular Endothelial Growth Factor (VEGF) in hepatocellular carcinoma - the third-largest cause of cancer deaths - could serve as prognostic markers in determining the aggressiveness of the cancer, according to Italian researchers at the Sbarro Institute for Cancer Research (Clin. Cancer Res., May 15. 2004). The scientists discovered an inverse correlation between the expression of Rb2 and VEGF in the tumours: The lower the Rb2 expression and the higher the VEGF expression, the more aggressive was the liver cancer - regardless of whether the tumour was in an early or an advanced stage. The new markers may provide a way for an improved cancer prognosis which is independent of the tumour grading. A better prognosis would open up the way to an improved prevention of the deadly metastases.

ItalyItaly

12.06.2011

Milan – Everyone agrees that Italy is not Greece, but it is common wisdom that the country could also be doing better. Considering the meagre growth of the Italian economy in the last decade however, data fom the 2011 survey of...

ItalyItaly

01.04.2011

Milan – Italian drugmaker Newron Pharmaceuticals S.p.A. and Merck Serono have broadened the scope of their 5-year-old collaboration on CNS drugs. In addition to the Parkinson’s treatment safinamide, under the terms of a new...

ItalyItaly

16.02.2011

Milan/Berlin – Swiss-Italian biotech Philogen SpA has revoked its plan to sell a 23% stake worth EUR65.3m and go public on the Milan stock exchange this Friday. The move came after German Bayer HealthCare unexpectedly terminated...

ItalyItaly

06.02.2011

Rome – The EUR2.5m ERC Advanced Grants are the Grammies of European science – not in the same league as a Nobel Prize, but still a lucrative honor. In the fourth round since 2007, the European Research Council awarded some a590m...

ItalyItaly

29.11.2010

Modena/London – Researchers from Germany, Italy and the UK have identified a molecule that is key to the onset of addiction and also involved into memory formation (EMBO Journal, doi:10.1038/emboj.2010.279). According to results...

ItalyItaly

09.11.2010

Genoa/Philadelphia — The inexpensive anti-gout drug allopurinol can counteract colorectal adenoma progression, according to data presented yesterday at the 9th Annual AACR Frontiers in Cancer Prevention Research Conference...

Displaying results 11 to 20 out of 181

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-italy/browse/1/article/liver-cancer-prognosis.html

Product of the week

Products

Events

All Events

Current issue

All issues